Multaq Safety Concerns Over Cardiovascular Injury and Liver Failure
Maltaq was approved by the FDA in July 2009 for the treatment of abnormal heart rhythms. Soon after entering the market, disturbing reports of liver failure were reported with the drug. More recently, the FDA has warned of association with severe, even life threatening, cardiovascular problems. I encourage all my readers to discuss these new
Read MoreConsumer Alert! Fosamax Linked to Esphogeal Cancer
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Another serious safety concern with Fosamax! Can this drug get any worse in terms of a safety profile? Today FDA Communications issued a warning derived from a study from the UK General Practice Database that users of Fosamax of three years
Read MoreConsumer Alert! Transvaginal Mesh Warnings
This really big news concerning vaginal mesh dangers. Today, in an abrupt change from their position in October 2008, the FDA issued an update informing patients that serious complications associated with surgical mesh for transvaginal repair of POP are not rare. This is a change from what the FDA previously reported on October 20, 2008.
Read MoreMichael Brady Lynch Lectures at AAJ Annual Convention
Today, I was honored with the privilege of lecturing to over 150 attorneys at Litigation at Sunrise II at the American Association for Justice’s Annual Convention in New York City. It has been a great five days in New York. Although my lecture was very early in the morning, the attendance was great and the
Read MoreMichael Brady Lynch Appointed Chair of Nexium Litigation Group
Today was another busy day at the American Association for Justice’s Annual Convention in New York City. Of special note, I was honored with the appointment as Chair of the Nexium / Proton Pump Inhibitor Litigation Group. Proton Pump Inhibitors (PPI) like Nexium and Prilosec have been associated with severe bone breaks after long-term use
Read MoreMichael Brady Lynch Appointed Chair of AAJ Crestor Litigation Group
Yesterday I arrived in New York City for the start of the American Association for Justice’s Annual Convention in New York City. It is exciting to be back in New York City, and I look forward to a great convention. Today, I had the pleasure of being appointed the Chair of the newly formed American
Read MorePaxil and Prozac Pose Increased Risk for Heart Birth Defects
This shouldn’t come as a surprise, but that doesn’t mean it is any less of a breach of public trust. Today, Finnish researchers warned doctors that they should avoid prescribing Paxil or Prozac to pregnant women, due to the potential risk of heart birth defects. In a study published in the Obstetric & Gynecology medical journal, researchers found that side
Read MoreAutism Linked to SSRI Antidepressant Usage
The longstanding association of birth defects with the use of SSRI antidepressants such as Lexapro, Celexa, Zoloft, Prozac, and Paxil is nothing new. However, there may be a connection between SSRI’s and autism, a recent study revealed. In the study, published in the journal Archives of General Psychiatry, researchers at Kaiser Permanente Northern California reviewed
Read MoreConsumer Alert! Chantix Cardiovascular Warnings
As my regular readers are aware, I have always maintained the position that Chantix was a drug that simply didn’t need to be on the market. Sure, smoking is an independent risk factor for a number of serious medical conditions. But with the high risk of suicide and suicidal thoughts that so frequently occur in
Read MoreActos Bladder Cancer Warning
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. This is just horrible news. Today the FDA issued a distrubing warning of an association between the drug Actos and bladder cancer. The warning comes after a review of data from a five-year analysis of an ongoing study of Actos by
Read More